Improving uptake of Fracture Prevention drug treatments: a protocol for Development of a consultation intervention (iFraP-D)
(2021)
Journal Article
Paskins, Z., Bullock, L., Crawford-Manning, F., Cottrell, E., Fleming, J., Leyland, S., Edwards, J. J., Clark, E., Thomas, S., Chapman, S. R., Ryan, S., Lefroy, J. E., Gidlow, C. J., Iglesias, C., Protheroe, J., Horne, R., O'Neill, T. W., Mallen, C., & Jinks, C. (2021). Improving uptake of Fracture Prevention drug treatments: a protocol for Development of a consultation intervention (iFraP-D). BMJ Open, 11(8), https://doi.org/10.1136/bmjopen-2021-048811
INTRODUCTION: Prevention of fragility fractures, a source of significant economic and personal burden, is hindered by poor uptake of fracture prevention medicines. Enhancing communication of scientific evidence and elicitation of patient medication-r... Read More about Improving uptake of Fracture Prevention drug treatments: a protocol for Development of a consultation intervention (iFraP-D).